Published in J Cachexia Sarcopenia Muscle on October 18, 2016
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol (2010) 24.08
Identification of ubiquitin ligases required for skeletal muscle atrophy. Science (2001) 12.98
Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol (2000) 6.57
Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol (2006) 6.00
Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis (1987) 5.00
Nuclear factor-kappaB: its role in health and disease. J Mol Med (Berl) (2004) 4.01
During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J Cell Biol (2009) 3.03
TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J (2005) 2.81
Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis (2010) 2.41
IL-6-induced skeletal muscle atrophy. J Appl Physiol (1985) (2004) 2.30
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015. J Cachexia Sarcopenia Muscle (2015) 2.20
Reactive oxygen intermediates in TNF signaling. Mol Immunol (2002) 2.20
Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci U S A (2003) 1.87
Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy. J Am Soc Nephrol (2006) 1.82
Mitogen-activated protein kinase (MAPK) pathway activation: effects of age and acute exercise on human skeletal muscle. J Physiol (2003) 1.78
Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann Neurol (2004) 1.77
Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J (2011) 1.67
The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol (2013) 1.67
The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int (2013) 1.64
Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass. Cell Metab (2013) 1.49
Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways. FASEB J (2010) 1.46
Signaling pathways controlling skeletal muscle mass. Crit Rev Biochem Mol Biol (2013) 1.43
Effect of uremia on structure and function of immune system. J Ren Nutr (2012) 1.43
Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol (1991) 1.40
Toll-like receptors and danger signaling in kidney injury. J Am Soc Nephrol (2010) 1.39
Malnutrition, cardiac disease, and mortality: an integrated point of view. Am J Kidney Dis (1998) 1.22
Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol (2014) 1.21
Aberrant p38 mitogen-activated protein kinase signalling in skeletal muscle from Type 2 diabetic patients. Diabetologia (2003) 1.20
The pivotal role of cytokines in muscle wasting during cancer. Int J Biochem Cell Biol (2005) 1.16
Toll-like receptors: emerging concepts in kidney disease. Curr Opin Nephrol Hypertens (2007) 1.15
Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule. J Immunol (2010) 1.12
Temporal alterations in protein signaling cascades during recovery from muscle atrophy. Am J Physiol Cell Physiol (2003) 1.12
Reliability of the 7-point subjective global assessment scale in assessing nutritional status of dialysis patients. Adv Perit Dial (1999) 1.12
U1 RNA induces innate immunity signaling. Arthritis Rheum (2004) 1.07
Apoptosis and myostatin mRNA are upregulated in the skeletal muscle of patients with chronic kidney disease. Kidney Int (2011) 1.07
Regulation of muscle growth by pathogen-associated molecules. J Anim Sci (2008) 1.00
Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease. Kidney Int (2013) 0.98
Subjective global assessment of nutritional status is strongly associated with mortality in chronic dialysis patients. Am J Clin Nutr (2009) 0.93
In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection. Kidney Int (2004) 0.93
Inflammation based regulation of cancer cachexia. Biomed Res Int (2014) 0.91
Skeletal muscle protein synthesis and degradation in patients with chronic renal failure. Kidney Int (1994) 0.89
Role of IGF-I and the TNFα/NF-κB pathway in the induction of muscle atrogenes by acute inflammation. Am J Physiol Endocrinol Metab (2012) 0.88
Regulation of innate immune responses by Toll-like receptors. Jpn J Infect Dis (2001) 0.87
Proteolytic mechanisms, not malnutrition, cause loss of muscle mass in kidney failure. J Ren Nutr (2006) 0.87
Hemodialysis modulates gene expression profile in skeletal muscle. Am J Kidney Dis (2006) 0.85
Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria. Kidney Int (2014) 0.83
Peripheral tissue release of interleukin-6 in patients with chronic kidney diseases: effects of end-stage renal disease and microinflammatory state. Kidney Int (2006) 0.83
Effects of uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases. Kidney Int (2008) 0.80
Progressive inflammation and wasting in patients with ESRD. Clin J Am Soc Nephrol (2014) 0.80
Uremia attenuates growth hormone-stimulated insulin-like growth factor-1 expression, a process worsened by inflammation. Kidney Int (2010) 0.79
Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survival. Clin J Am Soc Nephrol (2011) 0.76
Interorgan handling of fibroblast growth factor-23 in humans. Am J Physiol Renal Physiol (2016) 0.75
Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy. J Nephrol (2017) 0.75